Surgical risk and cause of death among octogenarian and nonagenarian patients with colorectal cancer: a Japanese multicenter study
Japanese Journal of Clinical Oncology · 2025
DOI: 10.1093/jjco/hyae171 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Shintaro Hashimoto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
The number of elderly people undergoing surgery for colorectal cancer has been increasing. We examine prognosis, including risks of surgery by age and cancer- and noncancer-related deaths.
Methods
This study retrospectively reviewed 1830 patients who underwent curative resection colorectal surgery. Patients were divided into oldest-old (>85 years old, n = 49), elderly (75–84 years old, n = 637), and young (<75 years old, n = 1144) patient groups.
Results
Physical status was poorer (P < .001), postoperative complications were more frequent (49.0% vs. 20.9% vs. 18.4%; P < .001), and adjuvant chemotherapy was less frequent (0% vs. 44.3% vs. 83.5%; P < .001) as patients got older. Multivariate analysis revealed oldest-old [odds ratio (OR) 4.373, 95% confidence interval (CI) 2.362–8.110; P < .001] as independent predictors of postoperative complications. Elderly patients [hazard ratio (HR) 2.494, 95%CI 1.707–3.642; P < .001], oldest-old patients (HR 5.969, 95%CI 3.229–11.035; P < .001), poor physical status (HR 2.546, 95%CI 1.694–3.827; P < .001), and postoperative complications (HR 1.805, 95%CI 1.252–2.602; P = .001) were predictive factors for noncancer-specific survival.
Conclusions
Elderly patients had many complications and a higher risk of dying from other causes. Surgical risk and general condition must be considered when deciding the appropriateness of surgery and adjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
- Department of Surgery, Sasebo City General Hospital, 9-3 Hirasemachi, Nagasaki, 857-8511, Japan.
- Department of Surgery, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Omura, Nagasaki, 856-8562, Japan.
- Department of Surgery, Isahaya General Hospital, 24-1 Isahaya, Nagasaki, 854-8501, Japan.
- Department of Surgery, Ureshino Medical Center, 4760-1 Ko, Ureshinomachi, Oaza, Shimojuku, Ureshino, Saga, 843-0393, Japan.
- Department of Surgery, Saiseikai Nagasaki Hospital, 2-5-1 Katafuchi, Nagasaki, 850-0003, Japan.
ORCID-Profile: Tetsuro Tominaga
Zitieren
APA
Hashimoto, S., Nonaka, T., Tominaga, T., Shiraishi, T., Noda, K., Ono, R., Hisanaga, M., Takeshita, H., Fukuoka, H., Fukuoka, K. T., Tanaka, K., Kunizaki, M., Sawai, T., & Matsumoto, K. (2025). Surgical risk and cause of death among octogenarian and nonagenarian patients with colorectal cancer: a Japanese multicenter study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae171
Vancouver
Hashimoto S, Nonaka T, Tominaga T, Shiraishi T, Noda K, Ono R, et al. Surgical risk and cause of death among octogenarian and nonagenarian patients with colorectal cancer: a Japanese multicenter study. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyae171
BibTeX
@article{Hashimoto2025,
author = {Hashimoto, Shintaro and Nonaka, Takashi and Tominaga, Tetsuro and Shiraishi, Toshio and Noda, Keisuke and Ono, Rika and Hisanaga, Makoto and Takeshita, Hiroaki and Fukuoka, Hidetoshi and Fukuoka, Kazuo To and Tanaka, Kenji and Kunizaki, Masaki and Sawai, Terumitsu and Matsumoto, Keitaro},
title = {Surgical risk and cause of death among octogenarian and nonagenarian patients with colorectal cancer: a Japanese multicenter study},
journal = {Japanese Journal of Clinical Oncology},
year = {2025},
doi = {10.1093/jjco/hyae171}
}
EUVIMED